Citations

Showing 10 of 108094 citations.

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
Deng, Yihong , Wallach, Joshua D. , Dhruva, Sanket S. , Quinto, Kenneth , Gandotra, Charu , Crown, William H. , Lyon, Timothy D. , Shah, Nilay D. , McCoy, Rozalina Grubina , Wallach, Joshua D , Lyon, Timothy D , Deng, Yihong , Polley, Eric C. , Herrin, Jeph , Noseworthy, Peter A. , Yao, Xiaoxi , Ross, Joseph S. , McCoy, Rozalina G.

Mayo Clinic

BMJ | October 3, 2022 | Volume: 379 | Issue: No issue available | Pages: e070717

10.1136/bmj-2022-070717 | PMID 36191949 Get It

Abstract Objective To emulate the GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study) trial using real world data before its publication. GRADE directly compared second line glucose lowering drugs for their ability to lower glycated hemoglobin A 1c (HbA 1c ). Design Observational study. Setting OptumLabs® Data Warehouse (OLDW), a nationwide claims database in the US, 25 January 2010 to 30 June 2019. Participants Adults with type 2 diabetes and HbA 1c 6.8-8.5% while using metformin monotherapy, identified according to the GRADE trial specifications, who also used glimepiride, liraglutide, sitagliptin, or insulin glargine. Main outcome measures The primary outcome was time to HbA 1c ≥7.0%. Secondary outcomes were time to HbA 1c >7.5%, incident microvascular complications, incident macrovascular complications, adverse events, all cause hospital admissions, and all cause mortality. Propensity scores were estimated using the gradient boosting machine method, and inverse propensity score weighting was used to emulate randomization of the treatment groups, which were then compared using Cox proportional hazards regression. Results 8252 people were identified (19.7% of adults starting the study drugs in OLDW) who met eligibility criteria for the GRADE trial (glimepiride arm=4318, liraglutide arm=690, sitagliptin arm=2993, glargine arm=251). The glargine arm was excluded from analyses owing to small sample size. Median times to HbA 1c ≥7.0% were 442 days (95% confidence interval 394 to 480 days) for glimepiride, 764 (741 to not calculable) days for liraglutide, and 427 (380 to 483) days for sitagliptin. Liraglutide was associated with lower risk of reaching HbA 1c ≥7.0% compared with glimepiride (hazard ratio 0.57, 95% confidence interval 0.43 to 0.75) and sitagliptin (0.55, 0.41 to 0.73). Results were consistent for the secondary outcome of time to HbA 1c >7.5%. No significant differences were observed among treatment groups for the remaining secondary outcomes. Conclusions In this emulation of the GRADE trial, liraglutide was statistically significantly more effective at maintaining glycemic control than glimepiride or sitagliptin when added to metformin monotherapy. Generating timely evidence on medical treatments using real world data as a complement to prospective trials is of value.
High‐resolution MRI to noninvasively characterize drainage around the carotid artery into the cervical lymph nodes
Keser, Zafer , Smith, Garrett , Cagil, Emin, Tufan, Fatih , Albayram, Önder , Keser, Zafer , Albayram, Sait

Mayo Clinic

Journal of Neuroimaging | October 3, 2022 | Volume: 33 | Issue: 1 | Pages: 102-108

10.1111/jon.13056 | PMID 36184887 Get It

AbstractBackground and PurposePrevious studies have proposed multiple parallel channels for waste clearance from the brain, though many gaps remain in our understanding of these systems. In this study, we examined periarterial fluid drainage around intracranial and extracranial segments of the internal carotid arteries (ICAs) from the brain into the cervical lymph nodes using a noninvasive and clinical‐based method.MethodsEighty‐one subjects (45 females, aged 15‐80 years old) with nonlesioned epilepsy underwent high‐resolution 3‐dimensional T2‐weighted fluid‐attenuated inversion recovery (FLAIR) MRI. We utilized a noninvasive and clinical‐based method with a manual semiautomated approach to characterize the periarterial lymphatic system's maximum thickness and signal intensities along the ICAs using high‐resolution 3‐dimensional FLAIR imaging. We conducted group comparisons and correlation analyses to investigate sex‐ and age‐based trends. Results were corrected with Bonferroni's test for multiple comparisons, and we performed power analysis for sample size calculations.ResultsUsing high‐resolution FLAIR images, we show evidence that fluid drainage emerges around the ICA petrous segment and joins lymphatic flow from cranial nerves in the upper neck, with this flow ultimately draining into the cervical lymph nodes bilaterally. Lymphatic signal at the petrous segment level was significantly thinner in females compared to males bilaterally (w = 413, p = .0001 on the right, w = 356, p < .0001 on the left). Lymphatic drainage around the petrous segments of the ICAs bilaterally was thicker with age in males but not in females.ConclusionsWe describe the in vivo high‐resolution imaging characteristics of periarterial fluid drainage along the vessel walls of ICAs. This represents a potentially major channel for brain waste clearance. We also report interesting sex‐ and age‐based trends in these structures within our cohort.
Factors Facilitating Academic–Community Research Partnerships With African American Churches: Recruitment Process for a Community-Based, Cluster Randomized Controlled Trial During the COVID-19 Pandemic
Tadese, Kristene , Jenkins, Sarah M. , Aycock, Dawn M. , Brewer, LaPrincess C. , Patten, Christi A. , Brewer, LaPrincess C , Jones, Clarence , Hayes, Sharonne N. , Burke, Lora E. , Cooper, Lisa A.

Mayo Clinic

Health Promotion Practice | October 3, 2022 | Volume: 25 | Issue: 1 | Pages: 8-12

10.1177/15248399221118394 | PMID 36189723 Get It

African American (AA) churches are valuable partners in implementing health promotion programming (HPP) to combat health disparities. The study purpose was to evaluate AA church characteristics associated with enrollment into the FAITH! (Fostering African American Improvement in Total Health) Trial, a community-based, cluster randomized controlled trial (RCT) of a mobile health intervention for cardiovascular health promotion among AA churches. Churches located in Minneapolis-St. Paul and Rochester, Minnesota were invited to complete an electronic screening survey and follow-up telephone interview including the PREACH (Predicting Readiness to Engage African American Churches in Health) tool to assess church characteristics and infrastructure for HPP. The primary outcome was church enrollment in the FAITH! Trial. Key predictors included overall PREACH scores and its subscales (Personnel, Physical Structure, Faith-based Approach, Funding), congregation size, and mean congregation member age. Of the 26 churches screened, 16 (61.5%) enrolled in the trial. The enrolled churches had higher overall mean PREACH scores (36.1 vs. 30.2) and subscales for Personnel (8.8 vs. 5.6), Faith-based Approach (11.0 vs. 9.6), and Funding (7.3 vs. 4.8) compared with non-enrolled churches; all differences were not statistically significant due to small sample size. Twelve (75.0%) of the enrolled churches had >75 members versus six (60.0%) of the non-enrolled churches. Twelve (80.0%) of the enrolled churches had an average congregation member age ≤54 years versus six (67.0%) of the non-enrolled churches. AA churches enrolling into a community-based RCT reported greater infrastructure for HPP, larger congregations, and members of younger age. These characteristics may be helpful to consider among researchers partnering with AA churches for HPP studies.
The value of high-resolution imaging in an occult peroneal intraneural ganglion cyst: illustrative case
Lenartowicz, Karina A. , Amrami, Kimberly K. , Strakowski, Jeffrey A. , Howe, B. Matthew, Spinner, Robert J.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | October 3, 2022 | Volume: 4 | Issue: 14 | Pages: No page available

10.3171/case22327 | PMID 36193032 Get It

BACKGROUND Foot drop is a common complaint with a broad differential diagnosis making imaging a key part of the diagnostic workup. The authors present a patient with an occult peroneal intraneural ganglion cyst who underwent imaging with high-frequency ultrasound (US) and high-resolution magnetic resonance imaging (MRI) to highlight the role of such techniques in cases of peroneal neuropathy. OBSERVATIONS Intraneural ganglion cysts are emerging as a common cause of common peroneal neuropathy. Imaging with US and MRI is a valuable tool used to illustrate the pertinent anatomy and identify the articular branch joint connection and cyst as part of the surgical planning and definitive management. LESSONS Intraneural ganglion cysts can be small or nearly invisible and failure to appreciate the intraneural cyst can lead to symptom or cyst persistence or recurrence. High-resolution modalities can be useful in the diagnosis and surgical planning of difficult cases.
Creating a Dementia Friendly Community in an African American Neighborhood: Perspectives of People Living with Dementia, Care Partners, Stakeholders, and Community Residents
Bergeron, Caroline D. , Robinson, Maisha T. , Willis, Floyd B. , Albertie, Monica, Wainwright, Jolita D., Fudge, Michelle R., Parfitt, Francine, Lucas, John A. , Albertie, Monica L, Parfitt, Francine C

Mayo Clinic

Journal of Applied Gerontology | October 3, 2022 | Volume: 42 | Issue: 2 | Pages: 280-289

10.1177/07334648221130055 | PMID 36184924 Get It

A dementia friendly community allows people with dementia and their care partners to remain engaged in their community well into the disease. This study presents the results of primary research aimed at exploring perceptions regarding building a dementia friendly community in an African American neighborhood in northeast Florida. Twelve focus groups and five interviews were conducted with people living with dementia, informal and formal care partners, community stakeholders and neighborhood residents, and analyzed using a grounded theory approach. Three main themes emerged from the analyses, including (1) perceived needs, (2) facilitators and barriers to being dementia friendly, and (3) opportunities for the community to become more dementia friendly. Study findings highlight the unique needs of a single African American neighborhood and the importance of culturally tailoring the dementia friendly model to diverse communities.
Role of Electroencephalogram (EEG) and Magnetic Resonance Imaging (MRI) Findings in Early Recognition and Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 Disease
Ho, Mai‐Lan , Petropoulou, Kalliopi, Sakonju, Ai , Chu, Dorna , Seratti, Guillermo, Palasis, Susan , Ho, Mai-Lan , Wirrell, Elaine

Mayo Clinic

Journal of Child Neurology | October 3, 2022 | Volume: 37 | Issue: 12-14 | Pages: 984-991

10.1177/08830738221128773 | PMID 36184928 Get It

Neuronal ceroid lipofuscinosis type 2 (CLN2) disease is a very rare neurodegenerative lysosomal storage disorder. Progression is rapid and irreversible, making early diagnosis crucial for timely treatment. A group of pediatric neurologists and neuroradiologists with expertise in CLN2 convened to discuss early electroencephalogram (EEG) and magnetic resonance imaging (MRI) findings in CLN2 diagnosis. Of 18 CLN2 cases, 16 (88.9%) had background slowing and 16 (88.9%) had epileptiform discharges on initial EEG. Seven of 17 (41.2%) patients who received intermittent low-frequency photic stimulation had a photoparoxysmal response. Initial MRIs showed subtle cerebellar (n = 14, 77.8%) or cerebral (n = 9, 50.0%) atrophy, white matter abnormalities (n = 11, 61.1%), and basal ganglia T2 hypointensity (n = 6, 33.3%), which became more apparent on follow-up MRI. The recognition of even subtle cerebellar atrophy and white matter signal changes in children aged 2-5 years who present with language delay, new-onset seizures, and an EEG with epileptiform discharges and background slowing should prompt investigation for CLN2. Because these early signs are not unique to CLN2, genetic testing is essential early in the diagnostic journey.
Validating Clinical Distal Radioulnar Joint Examination With Radiographic Parameters
Meaike, Jesse D. , Amrami, Kimberly K. , Kakar, Sanjeev , Meaike, Joshua J. , Kakar, Sanjeev

Mayo Clinic

HAND | October 3, 2022 | Volume: 19 | Issue: 3 | Pages: 442-447

10.1177/15589447221124276 | PMID 36189901 Get It

Background: The purpose of this study was to quantify the in vivo displacement of bilateral distal radioulnar joints (DRUJs) in resisted pronosupination. We hypothesize that this will demonstrate no appreciable difference between the left and right DRUJ, thus validating the concept of using the uninjured wrist as a control for physical examination as well as dynamic imaging studies. Methods: Thirty-two participants without a history of wrist pathology underwent a dynamic computed tomography (CT) protocol evaluating bilateral forearm rotation in neutral forearm rotation, 60° pronation, and 60° supination, including maximal isometric muscle loading. The DRUJ alignment, specifically the absolute degree and direction of subluxation of the ulna relative to the sigmoid notch, was then assessed using a modification of the radioulnar line method. Results: There was no significant difference in the mean displacement when comparing the right and left sides in neutral, pronation, or supination. The mean displacement was also compared between male and female patients, and there was no statistically significant difference in absolute displacement in neutral (male 0.99 mm vs female 1.38 mm) or supination (male −0.57 mm vs female −0.23 mm). However, the difference in pronation was statistically significant (male 2.69 mm vs female 3.26 mm). Of the 192 sequences, the measurements of displacement of the authors were within 1 mm 86% of the time (166 of 192). Conclusions: Dynamic CT of bilateral DRUJs in resisted pronation, supination, and neutral demonstrated symmetry between the right and left DRUJ, supporting the concept of using the contralateral side as a control to identify instability in an injured wrist.
Development and validation of IHS4 ‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa
Tzellos, Thrasyvoulos , Kyrgidis, Αthanassios , Alavi, Afsáneh , Gulliver, Wayne, Jemec, Gregor B. E. , Sayed, Christopher J. , Zee, Hessel H. van der , Kyrgidis, Athanassios , Alavi, A , Marzano, Angelo Valerio , Sayed, Christopher , Zouboulis, Christos C , Jemec, G B E , van der Zee, Hessel H , Straalen, Kelsey R. van , Goldfarb, Noah , Lowes, Michelle A , Prens, Errol P. , Zouboulis, Christos C.

Mayo Clinic

Journal of the European Academy of Dermatology and Venereology | October 3, 2022 | Volume: 37 | Issue: 2 | Pages: 395-401

10.1111/jdv.18632 | PMID 36184889 Get It

Abstract Background Validated, inclusive and easy‐to‐use outcomes for hidradenitis suppurativa are essential both in the clinical trial setting and clinical practice. The continuous IHS4 is a validated tool that dynamically assesses nodules/abscesses/draining tunnels and classifies disease severity as mild/moderate/severe. However, dichotomous outcomes are often required for clinical trials reporting. Objective To develop and validate a dichotomous outcome based on IHS4 that can be used in clinical trial settings and day‐to‐day clinical practice. Methods De‐identified data from the PIONEER‐I and ‐II studies were accessed through Vivli. Potential IHS4 thresholds were analysed using baseline to Week 12 data from adalimumab‐ and placebo‐treated hidradenitis suppurativa patients in the PIONEER‐I trial. The final threshold was chosen based on its ability to discriminate between patients treated with adalimumab or placebo and its association with reduction in inflammatory lesions. The final threshold was validated using data from baseline to Week 12 from adalimumab‐ and placebo‐treated hidradenitis suppurativa patients in both the PIONEER‐II and the combined PIONEER‐I and ‐II studies. Results The best performing cut‐off for the IHS4 was a 55% reduction of the IHS4 score (IHS4‐55). Patients who achieved the IHS4‐55 had an odd's ratio of 2.00 [95%‐CI 1.26–3.18, p = 0.003], 2.79 (95%‐CI 1.76–4.43, p < 0.001) and 2.16 (95%‐CI 1.43–3.29, p < 0.001) for being treated with adalimumab rather than placebo in PIONEER‐I, PIONEER‐II and the combined dataset, respectively. Additionally, the achievement of the IHS4‐55 was associated with a significant reduction in inflammatory nodules, abscesses and draining tunnels in all analysed datasets. Conclusions IHS4‐55, a novel dichotomous IHS4 version, based on a 55% reduction of the total score was developed. The IHS4‐55 performs similarly to the HiSCR in discriminating between adalimumab‐ and placebo‐treated hidradenitis suppurativa patients and shows significant associations with reductions in lesion counts. Moreover, the IHS4‐55 addresses some of the HiSCR drawbacks by dynamically including draining tunnels in a validated manner. By allowing the analysis of hidradenitis suppurativa patients with an abscess and nodule count below 3 but many draining tunnels, this outcome measure will improve inclusivity in clinical trials.
Feasibility of implementing cytology‐based cervical cancer screening national program in Lebanon: A pilot study
Seoud, Muhieddine , Jaafar, Iman , Hamadeh, Randa , Ammar, Walid , El‐Kak, Faysal, Atallah, David M.

Mayo Clinic

International Journal of Gynecology & Obstetrics | October 2, 2022 | Volume: 161 | Issue: 1 | Pages: 86-92

10.1002/ijgo.14489 | PMID 36183305 Get It

AbstractObjectiveTo review our national cervical cancer screening program using existing Ministry of Public Health primary healthcare centers (PHCs) and report the impact of women's knowledge, attitude, behavior, and practices on screening uptake and outcome.MethodsA cross‐sectional study on cervical cancer screening offered to sexually active Lebanese women aged 21 years and above visiting PHCs. Exclusions were history of complete hysterectomy, gynecologic cancers, and current pregnancy. Data were collected through a questionnaire and conventional cervical smear performed by trained healthcare providers and sent to one centralized cytopathology laboratory.ResultsOf 12 273 eligible women, 1.7% had an abnormal cervical smear test including 161 atypical squamous cells (ASC) of undetermined significance, 6 atypical glandular cells of undetermined significance, 16 low‐grade squamous intraepithelial lesion (SIL), 17 ASC—cannot rule out high‐grade SIL, 11 high‐grade SIL, and one invasive carcinoma. Knowledge and attitudes significantly affected participation in screening; women lacking awareness had rarely undergone a cervical smear.ConclusionIn Lebanon, cytology‐based cervical cancer screening is feasible within the PHCs. Positive screen incidence was low. Despite previous campaigns, a low level of knowledge persists, and affects women's com with the screening guidelines. Advocacy and awareness activities by key healthcare providers may help to improve participation.
African American race is a risk factor for severe hidradenitis suppurativa
Ulschmid, Caden, Serrano, Linda , Wu, Ruizhe , Roth, Gretchen M. , Sokumbi, Olayemi , Sokumbi, Olayemi , Ulschmid, Caden M.

Mayo Clinic

International Journal of Dermatology | October 2, 2022 | Volume: 62 | Issue: 5 | Pages: 657-663

10.1111/ijd.16428 | PMID 36183313 Get It

Abstract Background African Americans face a disproportionate incidence and prevalence of hidradenitis suppurativa (HS) in the United States, but HS severity and outcomes across racial and ethnic groups have not been well‐established while controlling for potentially confounding factors. In this retrospective cohort study, we investigated the associations of race and ethnicity with HS severity, emergency department (ED) visits, hospitalizations, and surgeries for HS while controlling for age, sex, body mass index (BMI), tobacco use, and insurance type. Methods We reviewed 1190 patients seen at the Medical College of Wisconsin with ≥3 encounters for HS between 1/1/2002 and 3/19/2019, excluding those without race data or an encounter in which HS was treated. Results A total of 953 patients were included; 470 patients were Black or African American non‐Hispanic (49%), 39 Hispanic (4%), 418 White non‐Hispanic (44%), and 26 other race or ethnicity (3%). Controlling for age, sex, BMI, tobacco use, and insurance type, Black patients had 2.8 times the odds of having Hurley stage III disease (95% CI 1.76–4.45, P < 0.001), 2.86 times the risk for experiencing an ED visit for HS (95% CI 2.12–3.88, P < 0.001), 2.25 times the risk for experiencing a hospitalization for HS (95% CI 1.42–3.56, P < 0.001), and 1.61 times the risk for experiencing a surgical encounter for HS (95% CI 1.34–1.95, P < 0.001) when compared to White patients. Conclusions African Americans face significant disparities in HS severity, ED visits, hospitalizations, and surgeries. The causes of these disparities must be further investigated and addressed.